BEAM THERAPEUTICS INC (BEAM) Stock Income Statement
NASDAQ:BEAM - Nasdaq - US07373V1052 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.58M | 63.52M | 377.71M | 60.92M | 51.84M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 494.30M | 479.09M | 554.19M | 399.40M | 444.31M | |||
| Research and Development | 381.56M | 367.56M | 437.38M | 311.59M | 387.09M | |||
| Selling, General, and Administrative Expenses | 112.74M | 111.53M | 116.81M | 87.81M | 57.22M | |||
| Operating Income | -430.72M | -415.57M | -176.49M | -338.48M | -392.47M | |||
| Interest Income/Expense | 41.72M | 37.27M | 35.58M | 59.40M | -1.01M | |||
| Other Income/Expense | 1.70M | 1.59M | 9.74M | 18.90M | 22.84M | |||
| Income Before Taxes | -387.30M | -376.70M | -131.16M | -260.18M | -370.64M | |||
| Income Tax | N/A | 39.00K | 1.37M | 3.41M | N/A | |||
| Net Income | -387.34M | -376.74M | -132.53M | -289.09M | -370.64M | |||
| EBITDA | -408.70M | -393.64M | -156.47M | -324.33M | -385.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.61 | -4.58 | -1.72 | -4.13 | -5.77 | |||
| Non GAAP EPS | -4.61 | -4.58 | -1.90 | -4.13 | -5.94 | |||
| Statistics | ||||||||
| Profit Margin | -609.24% | -593.13% | -35.09% | -474.54% | -714.97% | |||
| Operating Profit Margin | -677.47% | -654.25% | -46.73% | -555.61% | -757.08% | |||
All data in USD